Form 4 for BSX Boston Scientific
Accepted 2024-02-14 00:00:00 ET · period of report 2024-02-13 · accession 0001225208-24-002051 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-14 | 2024-02-13 | BSX | LUDWIG EDWARD J | Dir | M - OptEx | $17.37 | +7,000 | 48.4K | +17% | +$121.6K |
| D | 2024-02-14 | 2024-02-13 | BSX | LUDWIG EDWARD J | Dir | S - Sale+OE | $65.03 | -7,000 | 41.4K | -14% | -$455.2K |
| D | 2024-02-14 | 2024-02-13 | BSX | LUDWIG EDWARD J | Dir | M - OptEx | $0.00 | -7,000 | 9,818 | -42% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-13 | M | A | 7,000 | $17.37 | 48,374 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-13 | S | D | 7,000 | $65.03 | 41,374 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-02-13 | M | D | 7,000 | $0.00 | 9,818 | D | $17.37 · — to 2025-05-05 | 7,000 Common Stock | (F1) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in full on May 3, 2016, the date of the Company's 2016 annual meeting of stockholders. |